1 enrolling by invitation. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Enrolling by invitation 1 |
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Liver Cirrhosis: new trials by email Literature Review of Liver Cirrhosis trials Research Report on Liver Cirrhosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis Characteristics Prednisone, UDCA (Ursodeoxycholic acid) - Primary Biliary Cholangitis (PBC) | Phase 2 / Phase 3 | Enrolling by invitation | Han Ying | 244 | 2024-10-30 | 2025-11-28 |
Bile Duct Diseases (1) · Biliary Tract Diseases (1) · Cholestasis (1) · Cholestasis, Intrahepatic (1) · Digestive System Diseases (1) · Fibrosis (1) · Liver Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Prednisone (1) · Ursodeoxycholic Acid (1)
Han Ying (1)
China (1)